Skip to content

Postural Tachycardia Syndrome and Vasovagal Syncope in Relation to Serum Electrolytes and Adrenal Insufficiency

Postural Tachycardia Syndrome and Vasovagal Syncope in Relation to Serum Electrolytes and Adrenal Insufficiency Among Adults Attending the Main Assiut University Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05695755
Enrollment
50
Registered
2023-01-25
Start date
2022-11-01
Completion date
2023-10-31
Last updated
2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

POTS - Postural Orthostatic Tachycardia Syndrome

Brief summary

The present study aims to: 1. Estimate the prevalence of Postural Tachycardia Syndrome and vasovagal syncope among adults patients attend the Internal Medicine Clinic and ICU in period from 11/2022 to 10/2023 2. Detect of causes and the relationship between POTS and vasovagal syncope and serum electrolytes, and serum cortisol.

Detailed description

Postural Orthostatic Tachycardia Syndrome (POTS) is a common, although not so well-known variant of cardiovascular autonomic disorder characterized by an excessive heart rate increase on standing, symptoms of orthostatic intolerance and maybe syncope. The most common complaints are dizziness, weakness, rapid heartbeat and palpitation on standing. Moreover, patients often report physical deconditioning and reduced exercise capacity as well as headache, brain fog, dyspnea, gastrointestinal disorders and musculoskeletal pain. The etiology of POTS is largely unknown and three main hypotheses include an autoimmune disorder, abnormally increased sympathetic activity and catecholamine excess and sympathetic denervation leading to central hypervolemia and reflex tachycardia. The diagnostic criteria of POTS in this study is increasing hear rate from supine position to active standing by \> 30 beat per minute and positive poor mans man tilt table test. On the other hand, Vasovagal Reflex Syncope is the most frequent cause of transient loss of consciousness . The vasovagal reaction consists of vasodilatation and a heart rate decrease. During prolonged standing, this reaction is triggered by a reduction of the central blood volume because of pooling in the lower body veins, sometimes combined with other provocative factors . Patients with reflex syncope may suffer from recurrent loss of consciousness. Most of those patients also experience frequent presyncope, which can be just as incapacitating as syncope itself. Vasovagal syncope is usually not a dangerous condition, because episodes are self-limiting. However, the quality of life of patients with recurrences can be seriously affected . The rapid loss of consciousness and the possibility of trauma tax the patients sense of physical control and self-esteem.

Interventions

DIAGNOSTIC_TESTECHO, Serum electrolytes

echocardiography, serum electrolytes and cortisol level for all patients

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient Above 18 years. 2. Patient fulfilling diagnostic criteria of POTS increase heart rate from supine position to active standing by \> 30 beat per minute within 10 minutes and positive poor mans man tilt table test. 3. Patient with History of vasovagal syncope

Exclusion criteria

1. Age Below 18 Yrs old 2. patient with specific cardiac diseases 3. Patient with Neurologic disorders 4. patients on drugs that affect vasomotor tone of blood vessels

Design outcomes

Primary

MeasureTime frameDescription
Estimate the prevalence of Postural Tachycardia Syndrome and vasovagal syncope11/2022 to 10/2023Estimate the prevalence of Postural Tachycardia Syndrome and vasovagal syncope among adults patients attend the Internal Medicine Clinic and IC Detect of causes and the relationship between POTS and vasovagal syncope and serum electrolytes, and serum cortisol.

Countries

Egypt

Contacts

Primary ContactHossam M Abdelraheem
solimanhosam943@gmai.com01064962263
Backup ContactHala Kh Elshreef
halaelsherief@yahoo.com01120110000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026